ZFP69B
gene geneOn this page
Also known as ZKSCAN23BFLJ34293ZSCAN54B
Summary
ZFP69B (ZFP69 zinc finger protein B, HGNC:28053) is a protein-coding gene on chromosome 1p34.2, encoding Zinc finger protein 69 homolog B (Q9UJL9). May be involved in transcriptional regulation.
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II transcription regulatory region sequence-specific DNA binding activity. Involved in Golgi organization. Located in nucleolus.
Source: NCBI Gene 65243 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 70 total
- MANE Select transcript:
NM_023070
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:28053 |
| Approved symbol | ZFP69B |
| Name | ZFP69 zinc finger protein B |
| Location | 1p34.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | ZKSCAN23B, FLJ34293, ZSCAN54B |
| Ensembl gene | ENSG00000187801 |
| Ensembl biotype | protein_coding |
| Entrez | 65243 |
Gene structure
Transcript identifiers
Ensembl transcripts: 8 — 7 protein_coding, 1 retained_intron
ENST00000361584, ENST00000411995, ENST00000469416, ENST00000484445, ENST00000863980, ENST00000863981, ENST00000961485, ENST00000961486
RefSeq mRNA: 2 — MANE Select: NM_023070
NM_001369565, NM_023070
CCDS: CCDS452
Canonical transcript exons
ENST00000361584 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003600713 | 40454203 | 40454288 |
| ENSE00003642773 | 40462421 | 40463715 |
| ENSE00003847313 | 40450476 | 40451088 |
| ENSE00003888829 | 40457344 | 40457439 |
| ENSE00003895681 | 40456945 | 40457071 |
Expression profiles
Bgee: expression breadth ubiquitous, 170 present calls, max score 88.26.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 3.2832 / max 58.5584, expressed in 1206 samples.
FANTOM5 promoters (4 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 2386 | 3.0307 | 1159 |
| 201485 | 0.1680 | 58 |
| 2387 | 0.0736 | 28 |
| 2388 | 0.0109 | 3 |
Top tissues by expression
291 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 88.26 | gold quality |
| cortical plate | UBERON:0005343 | 82.57 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 81.55 | gold quality |
| ganglionic eminence | UBERON:0004023 | 78.37 | gold quality |
| stromal cell of endometrium | CL:0002255 | 74.00 | gold quality |
| ventricular zone | UBERON:0003053 | 72.28 | gold quality |
| islet of Langerhans | UBERON:0000006 | 70.70 | gold quality |
| secondary oocyte | CL:0000655 | 69.93 | gold quality |
| prefrontal cortex | UBERON:0000451 | 68.63 | gold quality |
| embryo | UBERON:0000922 | 66.73 | gold quality |
| oocyte | CL:0000023 | 64.29 | gold quality |
| vermiform appendix | UBERON:0001154 | 63.78 | gold quality |
| cingulate cortex | UBERON:0003027 | 63.38 | gold quality |
| right frontal lobe | UBERON:0002810 | 63.36 | gold quality |
| pancreas | UBERON:0001264 | 63.16 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 63.07 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 62.99 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 62.97 | gold quality |
| nucleus accumbens | UBERON:0001882 | 62.68 | gold quality |
| rectum | UBERON:0001052 | 62.54 | gold quality |
| neocortex | UBERON:0001950 | 62.54 | gold quality |
| gall bladder | UBERON:0002110 | 62.48 | gold quality |
| frontal cortex | UBERON:0001870 | 62.05 | gold quality |
| bone marrow cell | CL:0002092 | 61.06 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 60.94 | gold quality |
| lymph node | UBERON:0000029 | 60.64 | gold quality |
| caudate nucleus | UBERON:0001873 | 60.33 | gold quality |
| body of pancreas | UBERON:0001150 | 60.16 | gold quality |
| caecum | UBERON:0001153 | 60.15 | gold quality |
| leukocyte | CL:0000738 | 60.07 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-6142 | no | 36.53 |
| E-ANND-3 | no | 1.87 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
7 targeting ZFP69B, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-1290 | 99.59 | 69.90 | 2079 |
| HSA-MIR-181A-2-3P | 98.91 | 67.60 | 1168 |
| HSA-MIR-1246 | 98.54 | 66.21 | 959 |
| HSA-MIR-376A-5P | 97.70 | 65.61 | 863 |
| HSA-MIR-376C-3P | 97.63 | 68.88 | 1263 |
| HSA-MIR-12128 | 96.67 | 66.98 | 1471 |
| HSA-MIR-6834-5P | 96.25 | 64.88 | 823 |
Literature-anchored findings (GeneRIF, showing 1)
- ZNF643/ZFP69B Exerts Oncogenic Properties and Associates with Cell Adhesion and Immune Processes. (PMID:38003570)
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| drosophila_melanogaster | CG2712 | FBGN0024975 |
| drosophila_melanogaster | Phs | FBGN0036522 |
| drosophila_melanogaster | CG3281 | FBGN0260741 |
Paralogs (62): ZNF582 (ENSG00000018869), ZNF264 (ENSG00000083844), ZNF343 (ENSG00000088876), ZNF684 (ENSG00000117010), ZNF133 (ENSG00000125846), ZNF557 (ENSG00000130544), ZNF337 (ENSG00000130684), ZNF20 (ENSG00000132010), ZFP37 (ENSG00000136866), ZNF614 (ENSG00000142556), KRBOX4 (ENSG00000147121), ZNF599 (ENSG00000153896), ZNF19 (ENSG00000157429), ZNF589 (ENSG00000164048), PRDM9 (ENSG00000164256), ZNF180 (ENSG00000167384), ZNF558 (ENSG00000167785), ZNF35 (ENSG00000169981), ZNF778 (ENSG00000170100), ZNF439 (ENSG00000171291), ZNF440 (ENSG00000171295), ZNF556 (ENSG00000172000), ZNF554 (ENSG00000172006), ZNF596 (ENSG00000172748), ZNF80 (ENSG00000174255), ZNF266 (ENSG00000174652), ZNF25 (ENSG00000175395), ZNF77 (ENSG00000175691), ZNF169 (ENSG00000175787), ZNF404 (ENSG00000176222), ZNF491 (ENSG00000177599), ZNF620 (ENSG00000177842), ZNF619 (ENSG00000177873), ZNF875 (ENSG00000181666), ZNF329 (ENSG00000181894), ZFP90 (ENSG00000184939), ZNF566 (ENSG00000186017), ZNF529 (ENSG00000186020), ZNF749 (ENSG00000186230), ZNF555 (ENSG00000186300)
Protein
Protein identifiers
Zinc finger protein 69 homolog B — Q9UJL9 (reviewed: Q9UJL9)
Alternative names: Zinc finger protein 643
All UniProt accessions (2): E9PS66, Q9UJL9
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation. Essential for Golgi structural integrity.
Subcellular location. Nucleus.
Induction. Up-regulated by Golgi stress-inducing agent nigericin.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q9UJL9-1 | 1 | yes |
| Q9UJL9-2 | 2 |
RefSeq proteins (2): NP_001356494, NP_075558* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001909 | KRAB | Domain |
| IPR003309 | SCAN_dom | Domain |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036051 | KRAB_dom_sf | Homologous_superfamily |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
Pfam: PF00096, PF01352, PF13465
UniProt features (18 total): zinc finger region 9, cross-link 4, sequence variant 2, chain 1, domain 1, splice variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9UJL9-F1 | 63.17 | 0.13 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (4): 37, 40, 178, 235
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-212436 | Generic Transcription Pathway |
MSigDB gene sets: 59 (showing top):
YAGI_AML_WITH_INV_16_TRANSLOCATION, chr1p34, GOBP_ENDOMEMBRANE_SYSTEM_ORGANIZATION, HUANG_FOXA2_TARGETS_UP, GOBP_GOLGI_ORGANIZATION, GOCC_NUCLEOLUS, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, HATADA_METHYLATED_IN_LUNG_CANCER_UP, VERHAAK_GLIOBLASTOMA_PRONEURAL, PEDRIOLI_MIR31_TARGETS_UP, PHONG_TNF_RESPONSE_VIA_P38_COMPLETE, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, ZNF528_TARGET_GENES, ZNF610_TARGET_GENES, ZSCAN30_TARGET_GENES
GO Biological Process (3): regulation of transcription by RNA polymerase II (GO:0006357), Golgi organization (GO:0007030), regulation of DNA-templated transcription (GO:0006355)
GO Molecular Function (6): RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), DNA binding (GO:0003677), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (3): nucleus (GO:0005634), nucleolus (GO:0005730), nuclear lumen (GO:0031981)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| RNA Polymerase II Transcription | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| regulation of DNA-templated transcription | 1 |
| transcription by RNA polymerase II | 1 |
| organelle organization | 1 |
| endomembrane system organization | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| transcription cis-regulatory region binding | 1 |
| chromatin | 1 |
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| transition metal ion binding | 1 |
| nucleic acid binding | 1 |
| binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
| nuclear lumen | 1 |
| intracellular membraneless organelle | 1 |
| nucleus | 1 |
| intracellular organelle lumen | 1 |
Protein interactions and networks
STRING
340 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZFP69B | C3orf70 | A6NLC5 | 507 |
| ZFP69B | SMAP2 | Q8WU79 | 507 |
| ZFP69B | C16orf96 | A6NNT2 | 433 |
| ZFP69B | ELFN2 | Q5R3F8 | 391 |
| ZFP69B | POC1A | Q8NBT0 | 365 |
| ZFP69B | DCAF10 | Q5QP82 | 352 |
| ZFP69B | CYTH4 | Q9UIA0 | 349 |
| ZFP69B | ZDHHC23 | Q8IYP9 | 327 |
| ZFP69B | LYSMD3 | Q7Z3D4 | 324 |
| ZFP69B | SORCS1 | Q8WY21 | 320 |
| ZFP69B | NXPE3 | Q969Y0 | 311 |
| ZFP69B | CILP2 | Q8IUL8 | 311 |
| ZFP69B | SNED1 | Q8TER0 | 305 |
| ZFP69B | FAM174B | Q3ZCQ3 | 305 |
| ZFP69B | KLHL6 | Q8WZ60 | 301 |
IntAct
10 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| KRT40 | ZFP69B | psi-mi:“MI:0915”(physical association) | 0.560 |
| PRPF31 | ZFP69B | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZFP69B | HNRNPA2B1 | psi-mi:“MI:0915”(physical association) | 0.400 |
| ZFP69B | HNRNPDL | psi-mi:“MI:0915”(physical association) | 0.400 |
| ZFP69B | CNP | psi-mi:“MI:0914”(association) | 0.350 |
| PRPF31 | ZFP69B | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (13): KRT40 (Two-hybrid), ZFP69B (Affinity Capture-MS), ZFP69B (Two-hybrid), ZFP69B (Proximity Label-MS), ZFP69B (Proximity Label-MS), DBNL (Affinity Capture-MS), ACOT1 (Affinity Capture-MS), UGT1A10 (Affinity Capture-MS), SMAD3 (Affinity Capture-MS), CNP (Affinity Capture-MS), KCTD16 (Affinity Capture-MS), CORO1A (Affinity Capture-MS), ZFP69B (Affinity Capture-MS)
ESM2 similar proteins: A0JPL0, A3KN36, A7MBI1, A8MT65, B2RXC5, D3ZVT0, P08042, P21506, P51508, P52738, Q02525, Q06730, Q12901, Q2KI58, Q2M218, Q2M3W8, Q2M3X9, Q2VY69, Q49AA0, Q4R6J4, Q4V8A8, Q5FWF6, Q5HY98, Q5RB33, Q5RC79, Q5REF1, Q5T5D7, Q5VIY5, Q61967, Q6P2D0, Q6ZN11, Q86XU0, Q86Y25, Q8N782, Q8N859, Q8NB42, Q8TF39, Q8TF47, Q8WXB4, Q95K49
Diamond homologs: A0A087WUV0, Q96K75, Q99676, Q9HBT8, Q9UJL9, Q9UJN7, A0A1W2PQL4, A0JNB1, A0JPL0, A6NK53, A6QLU5, A6QPT6, A7MBI1, A8MT65, A8MUV8, A8MWA4, B2RXC5, B4DU55, B4DX44, E9PYI1, O14628, O75346, P0CH99, P0CI00, P17014, P17030, P17032, P17098, P51786, P85977, Q02386, Q06730, Q06732, Q0VAW7, Q12901, Q13360, Q14586, Q14588, Q14590, Q16587
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
70 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 59 |
| Likely benign | 5 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
744 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:40451085:GAAG:G | donor_gain | 1.0000 |
| 1:40454201:A:AG | acceptor_gain | 1.0000 |
| 1:40454202:G:GG | acceptor_gain | 1.0000 |
| 1:40456939:TTCTA:T | acceptor_loss | 1.0000 |
| 1:40456940:TCTA:T | acceptor_loss | 1.0000 |
| 1:40456941:CTA:C | acceptor_loss | 1.0000 |
| 1:40456942:TA:T | acceptor_loss | 1.0000 |
| 1:40457067:AGTGG:A | donor_loss | 1.0000 |
| 1:40457068:GTGG:G | donor_gain | 1.0000 |
| 1:40457070:GG:G | donor_gain | 1.0000 |
| 1:40457071:GG:G | donor_gain | 1.0000 |
| 1:40451087:AGG:A | donor_loss | 0.9900 |
| 1:40451089:G:C | donor_loss | 0.9900 |
| 1:40451089:G:GG | donor_gain | 0.9900 |
| 1:40454284:CCCAG:C | donor_loss | 0.9900 |
| 1:40454285:CCAGG:C | donor_loss | 0.9900 |
| 1:40454286:CAGGT:C | donor_loss | 0.9900 |
| 1:40454287:AG:A | donor_loss | 0.9900 |
| 1:40454288:GG:G | donor_loss | 0.9900 |
| 1:40454290:T:A | donor_loss | 0.9900 |
| 1:40456938:GTTCT:G | acceptor_loss | 0.9900 |
| 1:40456943:A:AG | acceptor_gain | 0.9900 |
| 1:40456944:G:GG | acceptor_gain | 0.9900 |
| 1:40457032:G:GT | donor_gain | 0.9900 |
| 1:40457032:G:T | donor_gain | 0.9900 |
| 1:40457038:A:AG | donor_gain | 0.9900 |
| 1:40457072:G:GG | donor_gain | 0.9900 |
| 1:40457073:T:TC | donor_loss | 0.9900 |
| 1:40457077:G:GT | donor_gain | 0.9900 |
| 1:40457339:A:G | acceptor_gain | 0.9900 |
AlphaMissense
3550 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 1:40462930:T:C | F316L | 0.999 |
| 1:40462932:T:A | F316L | 0.999 |
| 1:40462932:T:G | F316L | 0.999 |
| 1:40463350:T:C | F456L | 0.999 |
| 1:40463352:T:A | F456L | 0.999 |
| 1:40463352:T:G | F456L | 0.999 |
| 1:40463014:T:C | F344L | 0.998 |
| 1:40463016:C:A | F344L | 0.998 |
| 1:40463016:C:G | F344L | 0.998 |
| 1:40463098:T:C | F372L | 0.998 |
| 1:40463100:C:A | F372L | 0.998 |
| 1:40463100:C:G | F372L | 0.998 |
| 1:40463266:T:C | F428L | 0.998 |
| 1:40463268:C:A | F428L | 0.998 |
| 1:40463268:C:G | F428L | 0.998 |
| 1:40463434:T:C | F484L | 0.998 |
| 1:40463436:T:A | F484L | 0.998 |
| 1:40463436:T:G | F484L | 0.998 |
| 1:40463293:C:G | H437D | 0.997 |
| 1:40463369:T:C | L462P | 0.997 |
| 1:40463377:C:G | H465D | 0.997 |
| 1:40463518:T:C | F512L | 0.997 |
| 1:40463520:C:A | F512L | 0.997 |
| 1:40463520:C:G | F512L | 0.997 |
| 1:40462971:T:A | H329Q | 0.996 |
| 1:40462971:T:G | H329Q | 0.996 |
| 1:40463033:T:C | L350P | 0.996 |
| 1:40463043:T:A | H353Q | 0.996 |
| 1:40463043:T:G | H353Q | 0.996 |
| 1:40463117:T:C | L378P | 0.996 |
dbSNP variants (sampled 300 via entrez): RS1000057720 (1:40452814 C>T), RS1000088450 (1:40452495 C>T), RS1000354739 (1:40459277 T>G), RS1000694220 (1:40464072 C>G,T), RS1000707415 (1:40450283 T>A,G), RS1000759356 (1:40450528 G>A), RS1001432361 (1:40458464 G>A), RS1002275040 (1:40452352 A>G), RS1002306116 (1:40451988 G>A), RS1002639741 (1:40450476 G>A), RS1002824216 (1:40463809 A>G), RS1002878150 (1:40463462 A>C,G), RS1003132407 (1:40457211 T>C), RS1003184198 (1:40458419 C>T), RS1003212345 (1:40448934 G>A)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST006658_11 | Longevity | 3.000000e-06 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
33 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | decreases expression, increases expression | 4 |
| Valproic Acid | affects cotreatment, decreases expression, affects expression | 4 |
| Cyclosporine | affects expression, increases expression | 4 |
| trichostatin A | affects cotreatment, decreases expression | 2 |
| Phenylmercuric Acetate | affects cotreatment, decreases expression | 2 |
| Tetrachlorodibenzodioxin | decreases expression | 2 |
| Aflatoxin B1 | decreases expression, affects expression | 2 |
| TAK-243 | increases sumoylation | 1 |
| methylmercuric chloride | increases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| bisphenol A | increases expression | 1 |
| terbufos | decreases methylation | 1 |
| resorcinol | decreases expression | 1 |
| S-(1,2-dichlorovinyl)cysteine | increases expression | 1 |
| avobenzone | decreases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, decreases expression | 1 |
| abrine | decreases expression | 1 |
| dorsomorphin | affects cotreatment, decreases expression | 1 |
| Sunitinib | increases expression | 1 |
| Air Pollutants | increases abundance, increases expression | 1 |
| Fonofos | decreases methylation | 1 |
| Estradiol | affects cotreatment, increases expression | 1 |
| N-Nitrosopyrrolidine | increases expression | 1 |
| Parathion | decreases methylation | 1 |
| Quercetin | decreases expression | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Urethane | increases expression | 1 |
| Oxyquinoline | decreases expression | 1 |
| Okadaic Acid | increases expression | 1 |
Cellosaurus cell lines
1 cell lines: 1 transformed cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_XV97 | HEK293 eGFP-ZFP69B | Transformed cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.